Elbion/Biotie

Newron

This biopharmaceutical company develops and commercialises therapies for patients with central and peripheral nervous system disorders, such as schizophrenia and Parkinson's disease.

Tenacia Biotechnology

This biopharmaceutical company develops and commercialises therapeutics for patients with central nervous system disorders, including epilepsy, bipolar disorder and essential tremor.

Accure Therapeutics

This biopharmaceutical company develops central nervous system medicines to treat patients with conditions such as multiple sclerosis, Parkinson's disease, epilepsy and optic neuritis.

Biomia

The company develops nature-inspired small molecule therapeutics to treat central nervous system disorders for patients with mental health conditions and chronic pain.

Biogen Idec

This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.

BrainCells (BCI)

This biopharmaceutical company develops neurogenic compounds to treat central nervous system diseases for patients with psychiatric and neurological disorders.

Biohaven

This biopharmaceutical company develops therapeutics for patients with debilitating neurological, neuroinflammatory, and metabolic diseases, as well as immunological and oncology disorders.

Neuro3D SA

This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.